Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor

By Lee Mi-Woo   Seo Chul-Won   Kim Sang-We   Yang Hwa-Jeong   Lee Hae-Woong   Choi Jee-Ho   Moon Kee-Chan   Koh Jai-Kyoung  

Acta Dermato-Venereologica, Vol. 84, Iss. 1, 2003-12 ,pp. : 23-26

Medical Journals Limited

Access to resources Recommend Favorite

Possible Role of Epidermal Growth Factor in the Lesional Skin of Nodular Morphea

By  

Acta Dermato-Venereologica, Vol. 78, Iss. 4, 1998-07 ,pp. : 312-312

Medical Journals Limited

Access to resources Recommend Favorite

Involvement of P38 MAP kinase in the augmentation of UVB-mediated apoptosis via the epidermal platelet-activating factor receptor

By Landis Megan   Yi Qiaofang   Hyatt Ann-Marie   Travers Angela   Lewis Davina   Travers Jeffrey  

Archives of Dermatological Research, Vol. 299, Iss. 5-6, 2007-08 ,pp. : 263-266

Springer Publishing Company

Access to resources Recommend Favorite

Keratinocytes can differentiate into eccrine sweat ducts in vitro: involvement of epidermal growth factor and fetal bovine serum

By Shikiji T.   Minami M.   Inoue T.   Hirose K.   Oura H.   Arase S.  

Journal of Dermatological Science, Vol. 33, Iss. 3, 2003-12 ,pp. : 141-150

Elsevier

Access to resources Recommend Favorite

Fatal Toxic Epidermal Necrolysis Associated with Ceftazidine and Vancomycin Therapy: A Report of Two Cases

By Thestrup-Pedersen Kristian   Hainau Bo   Al'Eisa Abdullah   Al'Fadley Abdullah   Hamadah Issam  

Acta Dermato-Venereologica, Vol. 80, Iss. 4, 2000-09 ,pp. : 316-317

Medical Journals Limited

Access to resources Recommend Favorite